Romain Guyon graduated in Biosciences Engineering (Msc) from the Institut National des Sciences Appliquées of Lyon, France (INSA de Lyon) in 2018. This was followed by an Erasmus placement at Oxford and a 6-month internship in Paris in HiFiBio Therapeutics, where he worked on the development of a droplet microfluidic based high-throughput assay applied to monoclonal antibodies screening.
Romain was then awarded the NDM Prize Studentship at Oxford where he is currently studying for a DPhil in Clinical Medicine, based between the Jenner Institute and the Institute of Biomedical Engineering (IBME), working on the development of single dose vaccine technologies, and microparticle drug delivery.
Awards and Prizes
NDM Studentship Prize in 2018.
Romain is currently developping a single dose vaccine technology using microfluidic techniques, with the aim to encapsulate booster vaccine doses that release later in the body. He is interested in
- The encapsulation of antigens and vaccine formulations in biodegradable microparticles by microfluidic double emulsification
- The polymer formulation of the particles
- The characterisation of the mechanism and kinetics of release from these particles using various microscopy techniques (fluorescent, confocal, SEM)
- The evaluation in vitro and in a mice in vivo model by following the immune response to single dose encapsulated vaccine models compared to multiple injections
- Development of a delayed delivery technology for single dose vaccines using microfluidic techniques.